Business
GE HealthCare reports first quarter 2025 financial results
Revenue growth was 3% year-over-year; Organic revenue growth* was 4% Net income margin was 11.8% versus 8.0% for the prior year; Adjusted earnings before
About this update from Ge Healthcare Technologies Inc.
[{"type":"text","content":"\n\nRevenue growth was 3% year-over-year; Organic revenue growth* was 4%\n\n\n\nNet income margin was 11.8% versus 8.0% for the prior year; Adjusted earnings before interest and taxes (EBIT) margin* was 15.0% versus 14.7%\n\n\n\nDiluted earnings per share (EPS) were $1.23 versus $0.81 for the prior year; Adjusted EPS* was $1.01 versus $0.90\n\n\n\nCash flow from operating activities was $250 million versus $419 million for the prior year; Free cash flow* was $98 million versus $274 million\n\n\n\nUpdates full-year 2025 guidance\n\n\n\nBoard of Directors authorizes a $1 billion share repurchase program\n\n\n CHICAGO--(BUSINESS WIRE)--\nGE HealthCare (Nasdaq: GEHC) today reported financial results for the first quarter ended March 31, 2025.\n\nGE HealthCare President and CEO Peter Arduini said, “First quarter results reflect strong execution as we start the year with robust revenue, orders and profit growth, which were driven by strength in the U.S. We remain focused on delivering on our precision care and growth acceleration strategies, underscored by the closing of our acquisition of Nihon Medi-Physics, which we expect will increase global access to our next-generation radiopharmaceuticals. Regarding the current global trade environment, we are actively driving mitigation actions. We continue to see strong customer demand in many of the markets we serve and are well-positioned to drive long-term value as we invest in future innovation.”\n\nFirst quarter 2025 total company financial performance\n\n\nRevenues of $4.8 billion increased 3% reported and 4% on an Organic* basis year-over-year. Revenue growth was broad-based with growth in each segment, with overall strength in the U.S.\n\n\nTotal company book-to-bill was 1.09 times. Total company orders increased a record 10% organically year-over-year.\n\n\nNet income attributable to GE HealthCare was $564 million versus $374 million for the prior year, and Adjusted EBIT* was $715 million versus $681 million.\n\n\nNet income margin was 11.8% versus 8.0% for the prior year, up 380 basis points (bps). Adjusted EBIT margin* was 15.0% versus 14.7%, up 30 bps as both measures saw benefits from volume and productivity.\n\n\nDiluted EPS was $1.23 versus $0.81, up $0.41 from the prior year. Adjusted EPS* was $1.01 versus $0.90, up $0.11 from the prior year as both measures saw improved EBIT ...